Skip to main content
Livermore
Livermore
ZHEN

SG Americas Securities, LLC

SEC CIK
0001313360
Latest filing
Aug 7, 2026

RARE holding history

Ultragenyx Pharmaceutical Inc. in every 13F filed by SG Americas Securities, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RARE overviewAll 13F holders of RAREFull Q2 2026 holdings

Shares (Q2 2026)
53,668
Value
$1.79M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of RARE by SG Americas Securities, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202653,668$1.79M<0.1%+13,281+32.9%AddedHolders
Q1 202640,387$846.0K<0.1%+8,183+25.4%AddedHolders
Q4 202532,204$741.0K<0.1%−93,225−74.3%ReducedHolders
Q3 2025125,429$3.77M<0.1%+125,429NewHolders
Q2 20250$00.0%−237,573−100.0%Sold outHolders
Q1 2025237,573$8.60M<0.1%+227,908+2,358.1%AddedHolders
Q4 20249,665$407.0K<0.1%−2,648−21.5%ReducedHolders
Q3 202412,313$684.0K<0.1%−3,585−22.6%ReducedHolders
Q2 202415,898$653.0K<0.1%+15,898NewHolders
Q1 20240$00.0%−9,199−100.0%Sold outHolders
Q4 20239,199$440.0K<0.1%−2,957−24.3%ReducedHolders
Q3 202312,156$433.0K<0.1%+9,677+390.4%AddedHolders
Q2 20232,479$114.0K<0.1%−22,007−89.9%ReducedHolders
Q1 202324,486$982.0K<0.1%+659+2.8%AddedHolders
Q4 202223,827$1.10M<0.1%−10,976−31.5%ReducedHolders
Q3 202234,803$1.44M<0.1%+13,296+61.8%AddedHolders
Q2 202221,507$1.28M<0.1%+2,905+15.6%AddedHolders
Q1 202218,602$1.35M<0.1%+16,793+928.3%AddedHolders
Q4 20211,809$152.0K<0.1%−185−9.3%ReducedHolders
Q3 20211,994$180.0K<0.1%−135,090−98.5%ReducedHolders
Q2 2021137,084$13.1M0.1%+123,767+929.4%AddedHolders
Q1 202113,317$1.52M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.